Product Information
RUFINAMIDE 40 MG/ML SUSPENSION is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.2262 per ML under NDC 00054052863. Its NADAC has been published 284 times since Jan 20, 2021.
Strength
40 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054052863
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RUFINAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207363On Market Since
11/1/2020
Price Statistics
The NADAC for RUFINAMIDE 40 MG/ML SUSPENSION has been published 284 times since Jan 20, 2021, and over the history we have for it it has declined 92.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2262 per ML |
|---|---|
| All-time high | $3.2349 (Oct 13, 2021) |
| All-time low | $0.2262 (Jun 17, 2026) |
| 52-week high | $0.3887 |
| 52-week low | $0.2262 |
| Median price | $0.7738 |
| Average price | $1.1943 |
| Largest weekly change | -53.3% (Sep 20, 2023) |
| Weeks tracked | 284 |
| Tracking since | Jan 20, 2021 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RUFINAMIDE 40 MG/ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for RUFINAMIDE 40 MG/ML SUSPENSION, manufactured by Hikma Pharmaceuticals USA Inc., is $0.2262 per ML (NDC 00054052863), effective Jun 24, 2026.
How has the price of RUFINAMIDE 40 MG/ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for RUFINAMIDE 40 MG/ML SUSPENSION has declined 92.1%. It has been tracked across 284 weekly CMS publications since Jan 20, 2021.
What are the highest and lowest recorded NADAC prices for RUFINAMIDE 40 MG/ML SUSPENSION?
Since Jan 20, 2021, the NADAC for RUFINAMIDE 40 MG/ML SUSPENSION has ranged from a low of $0.2262 (Jun 17, 2026) to a high of $3.2349 (Oct 13, 2021), with a median of $0.7738 per ML.
Are there cheaper alternatives to RUFINAMIDE 40 MG/ML SUSPENSION?
6 NADAC-published products share the same active ingredient, strength, and dosage form as RUFINAMIDE 40 MG/ML SUSPENSION, but none are currently priced below it.
Who manufactures RUFINAMIDE 40 MG/ML SUSPENSION?
RUFINAMIDE 40 MG/ML SUSPENSION (NDC 00054052863) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification